The present application relates generally to cooling devices, systems, and methods for removing heat from subcutaneous lipid-rich cells, and more particularly, but not exclusively, to a cooling device having a plurality of controllable cooling elements to create a spatial cooling profile and/or a time-varying cooling profile in order to more efficiently affect subcutaneous lipid-rich cells.
Excess body fat increases the likelihood of developing various types of diseases such as heart disease, high blood pressure, osteoarthrosis, bronchitis, hypertension, diabetes, deep-vein thrombosis, pulmonary emboli, varicose veins, gallstones, hernias, and several other conditions.
In addition to being a serious health risk, excess body fat can also detract from personal appearance and athletic performance. For example, excess body fat can form cellulite, which causes an “orange peel” effect at the surface of the skin. Cellulite forms when subcutaneous fat protrudes into the dermis and creates dimples where the skin is attached to underlying structural fibrous strands. Cellulite and excessive amounts of fat are often considered to be unappealing. Thus, in light of the serious health risks and aesthetic concerns associated with excess fat, an effective way of controlling excess accumulation of body fat is urgently needed.
Liposuction is a method for selectively removing body fat to sculpt a person's body. Liposuction is typically performed by plastic surgeons and dermatologists using specialized surgical equipment that mechanically removes subcutaneous fat cells via suction. One drawback of liposuction is that it is a serious surgical procedure, and the recovery may be painful. Liposuction can have serious and occasionally even fatal complications. In addition, the cost for liposuction is usually substantial.
Conventional non-invasive treatments for removing excess body fat typically include topical agents, weight-loss drugs, regular exercise, dieting, or a combination of these treatments. One drawback of these treatments is that they may not be effective or even possible under certain circumstances. For example, when a person is physically injured or ill, regular exercise may not be an option. Similarly, weight-loss drugs or topical agents are not an option when they cause an allergic or negative reaction. Furthermore, fat loss in selective areas of a person's body cannot be achieved using general or systemic weight-loss methods.
Other non-invasive treatment methods include applying heat to a zone of subcutaneous lipid-rich cells. U.S. Pat. No. 5,948,011 discloses altering subcutaneous body fat and/or collagen by heating the subcutaneous fat layer with radiant energy while cooling the surface of the skin. The applied heat denatures fibrous septae made of collagen tissue and may destroy fat cells below the skin, and the cooling protects the epidermis from thermal damage. This method is less invasive than liposuction, but it still can cause thermal damage to adjacent tissue, and may be painful for the patient.
Another method of reducing subcutaneous fat cells is to cool the target cells as disclosed in U.S. Patent Publication No. 2003/0220674, the entire disclosure of which is incorporated herein. This publication discloses, among other things, reducing the temperature of lipid-rich subcutaneous fat cells to selectively affect the fat cells without damaging the cells in the epidermis. Although this publication provides promising methods and devices, several improvements for enhancing the implementation of these methods and devices would be desirable, including providing a plurality of controllable cooling elements to create a spatial cooling profile and/or a time-varying cooling profile in order to more efficiently affect subcutaneous lipid-rich cells.
U.S. Patent Publication No. 2003/0220674 also discloses methods for selective removal of lipid-rich cells and avoidance of damage to other structures including dermal and epidermal cells. A method for more efficiently and precisely controlling these effects is desirable. Therefore, a method for spatially cooling lipid-rich cells over a predetermined time-varying cooling profile, selected spatial cooling profile, or maintaining constant process parameters is also needed.
In the drawings, identical reference numbers identify similar elements or acts. The sizes and relative positions of elements in the drawings are not necessarily drawn to scale. For example, the shapes of various elements and angles are not drawn to scale, and some of these elements are arbitrarily enlarged and positioned to improve drawing legibility. Further, the particular shapes of the elements as drawn are not intended to convey any information regarding the actual shape of the particular elements, and have been solely selected for ease of recognition in the drawings.
A. Overview
The present disclosure describes devices, systems, and methods for cooling subcutaneous lipid-rich cells. The term “subcutaneous tissue” means tissue lying underneath the dermis and includes adipocytes (fat cells) and subcutaneous fat. It will be appreciated that several of the details set forth below are provided to describe the following embodiments in a manner sufficient to enable a person skilled in the relevant art to make and use the disclosed embodiments. Several of the details and advantages described below, however, may not be necessary to practice certain embodiments of the invention. Additionally, the invention can include other embodiments that are within the scope of the claims but are not described in detail with respect to
Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, the occurrences of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
The headings provided herein are for convenience only and do not interpret the scope or meaning of the claimed invention.
The present invention is directed toward a cooling device for removing heat from subcutaneous lipid-rich cells of a subject. The cooling device includes a plurality of cooling elements movable relative to each other so as to be conformable to the skin of the subject.
One aspect is directed toward a cooling device for removing heat from subcutaneous lipid-rich cells. The cooling device includes a plurality of cooling elements contained within interconnected frame members rotatable about at least one axis, a plurality of heat exchanging elements, and a housing. Alternatively, the cooling device includes a plurality of cooling elements contained on a flexible substrate. The cooling elements can use a number of cooling technologies including, for example, thermoelectric coolers, recirculating chilled fluid, vapor compression elements, or phase change cryogenic devices. One skilled in the art will recognize that there are a number of other cooling technologies that could be used and that the cooling elements need not be limited to those described here.
Another aspect is directed toward a cooling device having a plurality of cooling members using thermoelectric Peltier principles or other cooling technologies. The cooling device also includes a heat dissipating member in thermal communication with the cooling members and a plurality of interface members having heat exchanging surfaces configured to contact a subject's skin. The cooling members can be capable of reducing a temperature of a region such that lipid-rich cells in the region are affected while non-lipid-rich cells are not generally affected.
Further aspects include that the cooling device can include a plurality of interconnected hinged segments for rotating to conform to a body portion. Alternatively, the cooling elements may also be disposed on a flexible substrate and movable relative to each other.
Another aspect is directed toward a cooling device having a plurality of cooling members individually controlled to provide a spatial cooling profile and/or a time-varying cooling profile. The cooling profile can, for example, be configured to provide cooling members along a perimeter of the cooling device at a lower or a higher temperature than cooling members at an interior of the cooling device. Alternatively, the cooling profile can be configured to provide cooling members in regions of the cooling device at a lower or a higher temperature than cooling members in adjacent regions of the cooling device. Further aspects include that the cooling profile can vary over time to provide a decreasing or an increasing temperature profile during treatment.
Another aspect is directed toward a method of applying a cooling device having a plurality of cooling elements contained on a plurality of interconnected hinged segments, each adjacent pair of hinged cooling elements being rotatable about at least one axis. The cooling elements can have a plurality of heat exchanging surfaces capable of removing heat from the subject's skin. The method includes rotating hinged segments containing the cooling elements to achieve a desired configuration of the cooling device, cooling the heat exchanging surfaces of the plurality of cooling elements to a desired temperature, placing the plurality of cooled heat exchanging surfaces proximate to the subject's skin, and reducing the temperature of a region such that lipid-rich cells in the region are affected while non-lipid-rich cells in the region are not generally affected. Alternatively, the cooling elements may be disposed on a flexible substrate and movable relative to each other.
Further aspects include a method for applying and maintaining pressure on the contact region. Further aspects include securing the cooling device in position with a retention device. Further aspects include providing a time-varying profile to increase or decrease the temperature of the cooling elements over a selected time period. Further aspects include spatially varying the temperature of each cooling element of the cooling device to provide discrete cooling regions in the cooling device.
Another aspect is directed toward a system for removing heat from subcutaneous lipid-rich cells. The system includes a cooling device having a plurality of frame segments containing cooling elements movable relative to each other, the frame segments capable of achieving a desired orientation between each other, and a heat sink coupled to the cooling device to dissipate heat generated by the cooling device. In one embodiment, the frame segments are hinged. When placed proximate to a subject's skin, the plurality of cooling elements can be capable of reducing a temperature of a region such that lipid-rich cells in the region are affected while non-lipid-rich cells in the epidermis and/or dermis are not generally affected.
Further aspects include the cooling device being configured to follow the contours of the body. Further aspects include that the cooling device includes a handle and/or can include a strap or other retention device for holding the cooling device in a selected position. Further aspects include a control system for individually controlling the temperature of the cooling elements in a predetermined pattern. Further aspects include a processing unit for controlling a time-varying cooling profile of the cooling device.
B. System for Selectively Reducing Lipid-Rich Cells
The system 100 can further include a cooling unit 106 and supply and return fluid lines 108a-b connecting the cooling device 104 to the cooling unit 106. The cooling unit 106 can remove heat from a coolant to a heat sink and provide a chilled coolant to the cooling device 104 via the fluid lines 108a-b. Examples of the circulating coolant include water, glycol, synthetic heat transfer fluid, oil, a refrigerant, and any other suitable heat conducting fluid. The fluid lines 108a-b can be hoses or other conduits constructed from polyethylene, polyvinyl chloride, polyurethane, and other materials that can accommodate the particular circulating coolant. The cooling unit 106 can be a refrigeration unit, a cooling tower, a thermoelectric chiller, or any other device capable of removing heat from a coolant. Alternatively, a municipal water supply (i.e., tap water) can be used in place of the cooling unit.
As explained in more detail below, the cooling device 104 includes a plurality of thermoelectric cooling elements, such as Peltier-type thermoelectric elements, which can be individually controlled to create a custom spatial cooling profile and/or a time-varying cooling profile. The system 100 can further include a power supply 110 and a processing unit 114 operatively coupled to the cooling device 104. In one embodiment, the power supply 110 can provide a direct current voltage to the thermoelectric cooling device 104 to effectuate a heat removal rate from the subject 101. The processing unit 114 can monitor process parameters via sensors (not shown) placed proximate to the cooling device 104 through power line 116 to adjust the heat removal rate based on the process parameters. The heat transfer rate can be adjusted to maintain constant process parameters. Alternately, the process parameters can vary either spatially or temporally. The processing unit 114 can be in direct electrical communication through line 112, or alternatively, may be connected via a wireless communication. Alternatively, the processing unit 114 can be preprogrammed to provide a spatially distributed cooling profile and/or a time-varying cooling profile. The processing unit 114 can include any processor, Programmable Logic Controller, Distributed Control System, and the like.
In another aspect, the processing unit 114 can be in electrical communication with an input device 118, an output device 120, and/or a control panel 122. The input device 118 can include a keyboard, a mouse, a touch screen, a push button, a switch, a potentiometer, and any other device suitable for accepting user input. The output device 120 can include a display screen, a printer, a medium reader, an audio device, and any other device suitable for providing user feedback. The control panel 122 can include indicator lights, numerical displays, and audio devices. In alternative embodiments, the control panel 122 can be contained on the cooling device 104. In the embodiment shown in
C. Cooling Device Having a Plurality of Cooling Elements
The cooling device 104 is shown in a first relatively flat configuration in
One advantage of the plurality of rotatable heat exchanging surfaces is that the arcuate shape of the cooling device may concentrate the heat transfer in the subcutaneous region. For example, when heat exchanging surfaces are rotated about a body contour of a subject, the arcuate shape can concentrate heat removal from the skin.
The control system housing 202 can house a processing unit for controlling the cooling device 104 and/or fluid lines 108a-b and/or electrical power and communication lines. The control system housing 202 includes a harness port 210 for electrical and supply fluid lines (not shown for purposes of clarity). The control system housing 202 can further be configured to serve as a handle for a user of the cooling device 104. Alternatively, the processing unit may be contained at a location other than on the cooling device.
As shown in
The retention devices 208a and 208b are each shown as tabs 214, each having a slot 216 therein for receiving a band or elastomeric strap (not shown for purposes of clarity) to retain the cooling device 104 in place on a subject 101 during treatment. Alternatively, the cooling device may not contain any attached retention device and may be held in place by hand, may be held in place by gravity, or may be held in place with a band, elastomeric strap, or non-elastic fabric (e.g., nylon webbing) wrapped around the cooling device 104 and the subject 101.
As shown in
According to aspects of the embodiment, the cooling elements 302a-g may be affixed to the flexible substrate 350, or may be embedded in the flexible substrate 350. The flexible substrate 350 can be constructed from polymeric materials, elastomeric materials, and/or other suitable materials. The flexible substrate 350 can further be an elastomer such as silicone or urethane or can be a fabric, such as nylon. The flexible substrate 350 can also be a thin polymer such as polypropylene or ABS. The example of the flexible substrate 350 shown in
A plurality of heat exchanging elements 300a-g are contained on the frame 304. The heat exchanging elements 300a-g include cooling elements 302a-g having covers 301a-g. The covers 301a-g are affixed on a top side of the cooling elements 302a-g. The covers 301a-g may be affixed by various mechanical means as described further herein and as are known in the art. According to aspects of the invention, the covers 301a-g are fluidicly sealed to the cooling elements 302a-g. According to further aspects of the invention, the hinges 306a-g are configured so as to be adjacent to the subject's skin, in use, to maintain close proximity between the heat exchanging elements 300a-g when the heat exchanging elements 300a-g are in a rotated position.
The cooling elements 302a-g are attached by cooling element attachment means 307 to the frame 304 such that the first heat exchanging element 300a is located at the first segment 305a of the frame 304 and the second heat exchanging element 300b is located at the second segment 305b of the frame 304. The cooling element attachment means 307 are shown as a tab 313 extending from the frame 304 and a screw 315 fixedly attaching the tab 313 of the frame 304 to the cooling elements 302a-g. Alternatively, mechanical fixation devices as are known in the art may be used.
The cooling elements 302a-g of the cooling device 104 are generally configured to rotate to allow the cooling device 104 to conform to an arcuate portion of a subject 101. Once positioned on a subject 101, the cooling device 104 can further be strapped to or otherwise configured to be releasably attached to the subject 101. The cooling elements 302a-g can be configured to move relative to each other or rotate to position the cooling elements 302a-g for applying pressure to the treatment area during operation. Cooling elements 302a-g are movable or rotatable relative to each other such that cooling device 104 is conformable to the skin of the subject. These features are described in more detail below with reference to specific examples of the cooling devices.
The first cooling element 302a can include the cooling element housing 204a, a fluid inlet port 310 and a fluid outlet port 316a. The fluid inlet port 310 is fluidicly coupled to the supply fluid line 108a. As shown in
One expected advantage of providing cooling elements fluidicly coupled in series is a uniform flow rate through each cooling element 302a-g to provide more consistent cooling of the cooling device. Another expected advantage of providing cooling elements 302a-g fluidicly coupled in series is fewer supply lines into the cooling device to provide a more reliable, less cumbersome and easier to house fluid flow configuration for the cooling device.
The thermoelectric coolers 402 are contained within the segments 305a-g of the frame 304. According to aspects of the invention, the frame 304 may contain individual guides for each thermoelectric cooler 402. Alternatively, the thermoelectric coolers 402 may be retained on the cooling elements 302a-g, for example, by thermal epoxy or by a combination of solder, mechanical compression and thermal grease.
As shown in
By applying power to the thermoelectric coolers 402, heat can be effectively removed from the subject's skin to a circulating fluid in cooling elements 302a-g. For example, applying a current to the thermoelectric coolers 402 can achieve a temperature generally below 37° C. on the first side 404 of the thermoelectric coolers 402 to remove heat from the subject 101 via the interface members 418. The thermoelectric coolers 402 pull heat from the second side 406 to the first side 404 where the heat is then transferred to the circulating fluid. The cooling unit 106 then removes the heat from the circulating fluid.
The thermoelectric coolers 402 can be configured to withdraw a sufficient amount of heat quickly from the subject 101 without using a high-current power supply for the cooling unit 106. In order to facilitate thermal transfer, the interface members 418 can be an aluminum plate configured generally the same dimensions at the thermoelectric coolers 402. According to aspects of the invention, the thermoelectric coolers 402 can be Peltier-type thermoelectric elements rated at about 160 watts. As such, the cooling device 104 can cool a portion of the subject's skin from a temperature of about 37° C. to about −20° C. quickly and effectively. The cooling unit 106 can use a normal voltage power supply (e.g., 120 VAC) because the power consumption is not excessive. This enables the system to be used in hospitals, clinics, and small offices without more costly high voltage electrical systems.
According to further embodiments of the invention,
In one example, the sensing element 710 can be a temperature sensor configured to measure the temperature of the first heat exchanging surface 420 and/or the temperature of the skin of the subject 101. For example, the temperature sensor can be configured as a probe or as a needle that penetrates the skin during measurement. Examples of suitable temperature sensors include thermocouples, resistance temperature devices, thermistors (e.g., neutron-transmutation-doped germanium thermistors), and infrared radiation temperature sensors. In another example, the sensing element 710 can be an ultrasound sensor configured to measure crystallization or change in viscosity of subcutaneous fat in the treatment region of a subject. In yet another example, the sensing element 710 can be an optical or infrared sensor configured to monitor an image of the treatment region to detect, for example, epidermal physiological reactions to the treatment. The sensing element 710 can be in electrical communication with the processing unit 114 via, for example, a direct wired connection, a networked connection and/or a wireless connection.
Accordingly, the cooling device 104 can be in electrical communication with the processing unit 114, and the cooling temperature can be automatically adjusted by the processing unit 114. According to further aspects of the invention, the temperature of the interface member 418 can be sensed by the sensing element 710 and the sensed electrical signal can be converted by the processing unit 114 into a process value for the temperature. In one embodiment, the processing unit 114 can include a Proportional, Integral and Derivative controller, which can adjust the power output to the thermoelectric coolers 402 to achieve and/or maintain the desired temperature.
According to further aspects of the invention, the sensing element 710 can alternatively be a pressure sensor to sense the pressure exerted by the cooling element 302a against the subject 101. In one embodiment, the interface member 418 can be attached to the frame 304 such that pressure applied against the heat exchanging element 300a is transferred via the housing 204a to the pressure sensor. The pressure sensor can alternatively be configured to sense the pressure in the fluid chamber 610 for monitoring pressure variations in the fluid chamber 610. Alternatively, the pressure could be inferred from force and the known contact area of the cooling elements. For example, the sensing element 710 can be any type of load-sensitive pressure sensing element such as a load cell (model #LC201-25) produced by OMEGA Engineering, Inc. in Stamford, Conn. Direct pressure measurement could also be performed by placing a pressure measurement membrane directly at the interface between the cooling element and the skin.
The cooling elements 302a-g can have many additional embodiments with different and/or additional features without detracting from the operation of the elements. For example, an adjacent cooling element may or may not have a sensing element proximate to the heat exchanging surface. Alternatively, the cooling elements can be constructed from a material that is different from that of the adjacent cooling element.
As shown in
According to alternative aspects of the embodiment, the planar matrix 824 can further include temperature or other sensors (not shown) captured between the interface plate and the thermoelectric coolers and/or can have a separate sleeve that houses temperature sensors as further discussed herein.
D. Operation of the Cooling Device
Without being bound by theory, it is believed that, in operation, effective cooling from the cooling device 104, which cools through conduction, depends on a number of factors. Two exemplary factors that impact heat removal from the skin area are the surface area of the cooling element and the temperature of the interface member. When conduction is between two materials that are placed in physical contact, i.e., the skin and the cooling element, there is a certain amount of thermal resistance known as contact resistance. The contact resistance takes the form of a temperature differential between the two materials. Higher contact resistance means less effective cooling; therefore, in the cooling device it is desirable to minimize contact resistance.
One means to minimize contact resistance and maximize the contact surface area is with an interface member that is flexible and will conform to the natural body contours. According to alternative aspects, contact pressure can be reduced by increasing the pressure of the applicator on the skin. Surface pressure has an additional benefit in a skin cooling application. Sufficient pressure on the skin can cause internal capillaries to constrict, temporarily reducing the flow of blood into the treatment region. Reduced blood flow into the treatment area allows the area being cooled to cool more efficiently and improves the effectiveness of the treatment.
Thus, according to aspects of the invention, the cooling device also incorporates a flexible strapping material or belt that wraps around the subject following the curvature of the cooling device. By tightening the strapping, pressure is applied and can be maintained between the subject and the cooling device. According to aspects of the invention, the strap can incorporate a hoop or d-ring through which the strapping can be looped to provide mechanical advantage in tightening the strap. According to further aspects of the invention, the strap also incorporates Velcro or a latch or buckle to hold the pressure once the strap has been tightened.
In operation, an operator can hold the cooling device 104 in one hand by grasping the control system housing 202 or another type of suitable handle (not shown). Then the cooling elements 302a-g can be moved or rotated to achieve a desired orientation. The operator can place the cooling device 104 having the cooling elements 302a-g in the desired orientation proximate to the subject's skin to remove heat from a subcutaneous region of the subject 101. In one embodiment, the operator tightens retention devices 208a-b affixed to the cooling device 104 to apply pressure to the subject's skin. In another embodiment, the operator can manually press the cooling device 104 against the subject's skin. The operator can also monitor and control the treatment process by collecting measurements, such as skin temperatures, from the sensing element 710. By cooling the subcutaneous tissues to a temperature lower than 37° C., more preferably lower than 25° C., subcutaneous lipid-rich cells can be selectively affected. The affected cells are then resorbed into the patient through natural processes.
According to aspects of the invention, interface members 418, for example thin aluminum plates, are mounted to the bottom of the thermoelectric coolers in a manner to ensure good thermal contact between the thermoelectric coolers and the interface members. The interface members can be coupled to the cooling element by a variety of mechanical fixation means such as are known in the art. For example, the coupling means can include using thermally conductive epoxy or using thermal grease such as zinc oxide.
In operation, cooling is efficiently distributed through the heat exchanging elements 300a-g. For example, the cooling device includes a series of interface members 418 approximately 1 mm in thickness. The interface members 418 are in thermal communication with the cooling elements 302a-g by mechanical fixation such as thermal epoxy. The cooling elements 302a-g are cooled by a plurality of thermoelectric coolers to provide a more efficient cooling system to the treatment region. The cooling elements 302a-g are contained on segments that are movable relative to each other to conform to the contours of the subject's skin. Alternatively, the cooling elements are rotatable relative to each other, similar to the joined segments of a metal watch band, thus allowing the assembly to curve.
As designed, the interface members and cooling elements protect the thermoelectric coolers while maintaining good heat transfer between the thermoelectric coolers and the skin. The interface members are sized such that they do not present a significant thermal mass. In one design, each thermoelectric cooler could be 1″×1.5″. The interface member or aluminum plate could also be 1″×1.5″ with a thickness of 0.04″. If the thermoelectric coolers' cooling power is approximately 10 W, which is appropriate based on the heat flux expected to conduct from the skin, then the aluminum plate would cool from an ambient temperature of 20° C. to a treatment temperature of −10° C. in about 7 seconds. The change in internal energy of the plate is described by the following equation:
ΔE=ρ·V·C·ΔT
where ΔE is the change in internal energy, ρ is the material density, V is the material volume, C° is the heat capacity of the material, and ΔT is the temperature change. In the problem described above, the volume of the aluminum plate is V=1 in×1.5 in×0.04 in or 0.06 in3 (9.8×10−7 m3). For a typical grade of aluminum, C°=875 J/kg*° C. and ρ=2770 kg/m3. Solving the equation using these constants:
ΔE=2770 kg/m3*9.8×10−7 m3*875 J/kg*° C.*30° C.=71.3 J
If the thermoelectric coolers have a cooling power of 10 W, then 71.3 J could be removed from the aluminum plate in 7.1 seconds, as is shown in the calculation below:
71.3 J/(10 J/second)=7.13 seconds
A small gap or recess in the frame at the skin surface may be included in one embodiment. Prior to applying the cooling device to the skin, a thermally conducting fluid or coupling agent can be applied to the device and to the skin to minimize contact resistance and increase heat transfer between the cooling device and the skin. This coupling agent will fill the gap in the cooling device and allow for limited lateral conduction between the thermoelectric coolers' plates. This will create a more uniform temperature gradient across the surface area of the skin when the cooling is applied to the skin.
The coupling agent may be applied to the skin or to the interface member to provide improved thermal conductivity. The coupling agent may include polypropylene glycol, polyethylene glycol, propylene glycol, and/or glycol. Glycols, glycerols, and other deicing chemicals are efficient freezing-point depressants and act as a solute to lower the freezing point of the coupling agent. Propylene glycol (CH3CHOHCH2OH) is one exemplary component of deicer or non-freezing coupling agents. Other components include polypropylene glycol (PPG), polyethylene glycol (PEG), polyglycols, glycols, ethylene glycol, dimethyl sulfoxide, polyvinyl pyridine, calcium magnesium acetate, sodium acetate, and/or sodium formate. The coupling agent preferably has a freezing point in the range of −40° C. to 0° C., more preferably below −10° C. as further described in U.S. Provisional Application 60/795,799, entitled Coupling Agent For Use With a Cooling Device For Improved Removal of Heat From Subcutaneous Lipid-Rich Cells, filed on Apr. 28, 2006, herein incorporated in its entirety by reference.
One expected advantage of using the cooling device 104 is that subcutaneous lipid-rich cells can be reduced generally without collateral damage to non-lipid-rich cells in the same region. In general, lipid-rich cells can be affected at low temperatures that do not affect non-lipid-rich cells. As a result, lipid-rich cells, such as subcutaneous adipose tissue, can be affected while other cells in the same region are generally not damaged even though the non-lipid-rich cells at the surface are subject to even lower temperatures. Another expected advantage of the cooling device 104 is that it is relatively compact because the cooling device 104 can be configured as a handheld device. Yet another advantage is that the cooling device can be applied to various regions of the subject's body because the cooling elements 302a-g can be adjusted to conform to any body contour. Another expected advantage is that by pressing the cooling device 104 against the subject's skin, blood flow through the treatment region can be reduced to achieve efficient cooling. Yet another expected advantage is the use of pressure by constriction of the band to restrict blood flow to the treatment region and thereby reduce heat transfer (by mass transport). Thus, the band can not only provide a means for holding the cooling element in place, but also ensures good thermal contact between the cooling device and the skin, and further constricts the flow of blood in the treatment region. Still another expected advantage is that the plurality of the cooling elements 302a-g more efficiently remove heat from the skin compared to a single cooling element.
E. Spatially Controlled Cooling Element Profile
Many skin cooling devices rely on a relatively thick piece of aluminum or other conductive material between a thermoelectric cooler or other cooling source and the skin. When a cooling device is applied to a relatively insulating material, such as skin tissue, the aluminum plate becomes isothermal and maintains a constant temperature profile across the skin's surface. The drawback of this design is that when the device initially cools, or during thermal cycling, the thermal mass presented by the aluminum plate requires a large cooling power. This either translates into increased cooling time or increased power required from the cooling device or both.
According to aspects of the invention, the cooling device has a low thermal mass that will still maintain a constant temperature profile across the skin's surface. Further, according to aspects of the invention, a plurality of cooling elements are provided to allow different regions of the skin to be treated at different temperatures during one treatment session. There are some circumstances where it may be desirable to cool different regions of the skin to different temperatures or for different time periods. According to aspects of the invention, each thermoelectric cooler can be individually controlled to cool different regions of the skin to different temperatures and/or for different time periods and/or to ensure uniform temperature throughout the treatment region. One reason this may be desirable is that the composition of tissue is different in different locations of the body. Some regions have thicker layers of adipose tissue than others, which influence the thermal response of the skin. In other regions, the presence of bone or other organs will affect the heat transfer to the skin.
According to aspects of the invention, a spatially controlled temperature profile can provide more efficient cooling to the treatment region. The plurality of thermoelectric coolers allows the cooling device to accommodate spatial cooling. For example, thermoelectric coolers contained at the perimeter of the cooling device may have a lower or higher temperature or duration than thermoelectric coolers contained at the interior of the cooling device because of different boundary conditions in the different areas of the treatment zone. According to aspects of the invention, the cooling device will quickly and efficiently cool skin to a prescribed temperature. In addition, the cooling device described here has the additional ability to treat a large area in a single treatment while cooling different regions to different temperatures and/or for different durations.
This variation in localized cooling could alternatively be achieved using a cooling device that is relatively small such that many treatments are performed, cooling to different temperatures in different regions. However, this type of cooling device would require many treatments, thereby increasing the overall treatment time and the opportunity for operator error. In addition, a cooling device with a large thermal mass would require a longer cooling time during each treatment.
According to aspects of the invention, the device can accommodate spatially controlled cooling temperature profiles which may provide at least the following advantages: (1) increased efficiency; (2) decreased power consumption with comparable efficacy; (3) increased patient comfort; or (4) decreased treatment time. For example, according to aspects of the invention, the plurality of thermoelectric coolers will allow adjustment for anatomical differences between patients by selectively enabling or disabling portions of the apparatus based on anatomical differences of the patient. One example includes disabling the thermoelectric coolers around bony anatomy for patient comfort or for power conservation.
Alternatively, a particular pattern of controlled cooling may be customized to match an individual patient's pattern of cellulite, thus increasing the efficacy of the treatment. Similarly, treatment regions requiring a higher intensity of treatment may be pre-identified by ultrasound or other devices. The device can then be spatially controlled to provide higher intensity treatment to pre-identified areas. Further advantages include increased patient comfort and safety by allowing spatial control of cooling to accommodate unnatural anatomy (e.g. lumps, blemishes, nipples, hairy areas, scars, wounds, presence of implants, jewelry, or areas of heightened sensitivity.)
A further advantage of spatial control of the device includes utilizing only a subset of the cooling elements in order to treat only the region requiring treatment. It is advantageous to use one device that can accommodate small and large treatment regions without over treating (e.g. a large device that cannot be spatially controlled) or having to move the device multiple times thus extending the treatment time (e.g. a treatment device smaller than the treatment region). Thus, according to aspects of the invention, a selected region of thermoelectric coolers can be controlled to a few degrees warmer than another region of thermoelectric coolers. Alternatively, a first region of the cooling device can be turned off while a second region of the cooling device is activated, such that only a selected region of the subject is treated, thus limiting the treatment region. Other advantageous spatially controlled patterns include treating areas within the treatment region more intensely, conserving power by alternating thermoelectric coolers, increasing cooling at a perimeter in order to provide a uniform cooling pattern across the treatment area, and a combination of these spatially controlled patterns in order to increase treatment efficacy, reduce treatment time, decrease power consumption and provide for patient comfort and safety.
F. Time-Varying Cooling Profiles
In certain embodiments, once a desired temperature is achieved, the temperature of the region can be maintained for a predetermined period of time. The cooling cycle can be terminated by separating the heat exchanging surfaces 420a-g from the skin. After a certain period of time, if desired, the cooling device 104 can be reapplied to the same portion of the skin as described above until the lipid-rich cells are affected an amount sufficient to produce a desired reduction in lipid-rich cells. In another embodiment, the cooling device 104 can be applied to a different portion of the skin as described above to selectively affect lipid-rich cells in a different subcutaneous target region.
Alternatively, the cooling elements 302a-g can be controlled according to a predetermined time-varying cooling profile to cool, heat, re-cool, and/or cool in a stepped temperature pattern over time. In particular, according to aspects of the invention, patterns of controlled cooling over time provide at least the following advantages: (1) increased efficiency; (2) decreased power consumption with comparable efficacy; (3) increased patient comfort; or (4) decreased treatment time. One exemplary cooling pattern includes cooling to −5° for 15 minutes, warming to 30° for 5 minutes, cooling to −3° for 10 minutes. According to aspects of the present invention, any desired time-varying cooling profile can be programmed into the device. For example, a gradual or stepped cooling rate may decrease power requirements. Alternatively, a rapid cooling rate may be used in order to supercool the treatment region. Exemplary cooling rates include 5 to 1000 degrees per minute, more preferably 30 to 120 degrees per minute, and most preferably 35 to 100 degrees per minute.
One expected advantage of controlling the time-temperature profile of the device is that in practice, tissue is sensitive to cooling rates and thus tissue damage can be controlled by controlling the rate of cooling of the treatment region. Further, cooling the treatment region down over an extended period of time, or in phases, will increase patient comfort.
Another expected advantage of several of the embodiments described above is that the cooling device 104 can selectively reduce subcutaneous lipid-rich cells without unacceptably affecting the dermis, epidermis, and/or other tissues. Another expected advantage is that the cooling device 104 can simultaneously selectively reduce subcutaneous lipid-rich cells while providing beneficial effects to the dermis and/or epidermis. These effects may include: fibroplasia, neocollagenesis, collagen contraction, collagen compaction, collagen density increase, collagen remodeling, and acanthosis (epidermal thickening). In the treatment of cellulite, it is expected that dermal thickening above the herniating superficial fat lobules will help reduce the appearance of cellulite and improve the longevity of the effect. Another expected advantage is that the cooling device 104 can conform to various body contours of a subject by rotating or moving the cooling elements 302a-g to achieve a desired orientation. Yet another expected advantage is that the cooling device 104 can be configured as a handheld device for ease of operation. Furthermore, another expected advantage is that the system 100 with the handheld cooling device 104 and the rack-mounted processing unit 114 and cooling unit 106 are compact and efficient such that the method described above can be administered in an outpatient clinic or a doctor's office instead of in a hospital. Yet another expected advantage is that the cooling device 104 can be strapped in place to free the clinician's hands and allow the clinician to do other tasks with the treatment is in process.
G. Method of Applying Cooling Devices with a Plurality of Rotatable or Movable Cooling Elements
In operation, the angle between the heat exchanging surfaces 420 is selected by rotating or moving the cooling elements 302a-g. The angle between the cooling elements 320a-g is often selected to conform the heat exchanging surfaces 320a-g to various body contours of the subject 101 and/or a desired clamping arrangement. In the embodiment shown in
After configuring the cooling elements 302a-g, an operator places the cooling device 104 proximate to the skin of the subject 101. In the embodiment shown in
Applying the cooling device with pressure to the subject's skin or pressing against the skin can be advantageous to achieve efficient cooling. In general, the subject 101 has a body temperature of about 37° C., and the blood circulation is one mechanism for maintaining a constant body temperature. As a result, blood flow through the dermis and subcutaneous layer of the region is a heat source that counteracts the cooling of the subdermal fat. As such, if the blood flow is not reduced, cooling the subcutaneous tissues would require not only removing the specific heat of the tissues but also that of the blood circulating through the tissues. Thus, reducing or eliminating blood flow through the treatment region can improve the efficiency of cooling and avoid excessive heat loss from the dermis and epidermis.
By cooling the subcutaneous tissues to a temperature lower than 37° C., subcutaneous lipid-rich cells can be selectively affected. In general, the epidermis and dermis of the subject 101 have lower amounts of unsaturated fatty acids compared to the underlying lipid-rich cells forming the subcutaneous tissues. Because non-lipid-rich cells usually can withstand colder temperatures better than lipid-rich cells, the subcutaneous lipid-rich cells can be selectively affected while maintaining the non-lipid-rich cells in the dermis and epidermis. An exemplary range for the cooling elements 302a-g can be from about −20° C. to about 20° C., preferably from about −20° C. to about 10° C., more preferably from about −15° C. to about 5° C., more preferably from about −10° C. to about 0° C.
The lipid-rich cells can be affected by disrupting, shrinking, disabling, destroying, removing, killing, or otherwise being altered. Without being bound by theory, selectively affecting lipid-rich cells is believed to result from localized crystallization of highly saturated fatty acids at temperatures that do not induce crystallization in non-lipid-rich cells. The crystals can rupture the bi-layer membrane of lipid-rich cells to selectively necrose these cells. Thus, damage of non-lipid-rich cells, such as dermal cells, can be avoided at temperatures that induce crystal formation in lipid-rich cells. Cooling is also believed to induce lipolysis (e.g., fat metabolism) of lipid-rich cells to further enhance the reduction in subcutaneous lipid-rich cells. Lipolysis may be enhanced by local cold exposure, inducing stimulation of the sympathetic nervous system.
H. Computing System Software Modules
In operation, the input module 944 accepts an operator input, such as process setpoint and control selections, and communicates the accepted information or selections to other components for further processing. The database module 946 organizes records, including operating parameters 954, operator activities 956, and alarms 958, and facilitates storing and retrieving of these records to and from a database 952. Any type of database organization can be utilized, including a flat file system, hierarchical database, relational database, or distributed database, such as provided by a database vendor such as Oracle Corporation, Redwood Shores, Calif.
The process module 948 generates control variables based on sensor readings 960, and the output module 950 generates output signals 962 based on the control variables. For example, the output module 950 can convert the generated control variables from the process module 948 into 4-20 mA output signals 962 suitable for a direct current voltage modulator. The processor 942 optionally can include the display module 951 for displaying, printing, or downloading the sensor readings 960 and output signals 962 via devices such as the output device 120. A suitable display module 951 can be a video driver that enables the processor 942 to display the sensor readings 960 on the output device 120.
Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number, respectively. When the claims use the word “or” in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list.
The above detailed descriptions of embodiments of the invention are not intended to be exhaustive or to limit the invention to the precise form disclosed above. While specific embodiments of, and examples for, the invention are described above for illustrative purposes, various equivalent modifications are possible within the scope of the invention, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein can be combined to provide further embodiments.
In general, the terms used in the following claims should not be construed to limit the invention to the specific embodiments disclosed in the specification, unless the above detailed description explicitly defines such terms. While certain aspects of the invention are presented below in certain claim forms, the inventors contemplate the various aspects of the invention in any number of claim forms. Accordingly, the inventors reserve the right to add additional claims after filing the application to pursue such additional claim forms for other aspects of the invention.
The various embodiments described above can be combined to provide further embodiments. All of the U.S. patents, U.S. patent application publications, U.S. patent applications, foreign patents, foreign patent applications and non-patent publications referred to in this specification and/or listed in the Application Data Sheet are incorporated herein by reference, in their entirety. Aspects of the invention can be modified, if necessary, to employ cooling devices with a plurality of cooling elements, thermally conductive devices with various configurations, and concepts of the various patents, applications, and publications to provide yet further embodiments of the invention.
These and other changes can be made to the invention in light of the above-detailed description. In general, in the following claims, the terms used should not be construed to limit the invention to the specific embodiments disclosed in the specification and the claims, but should be construed to include all cooling that operates in accordance with the claims. Accordingly, the invention is not limited by the disclosure, but instead its scope is to be determined entirely by the following claims.
Number | Name | Date | Kind |
---|---|---|---|
681806 | Mignault | Sep 1901 | A |
889810 | Robinson | Jun 1908 | A |
2516491 | Swastek | Jul 1950 | A |
2766619 | Tribus et al. | Oct 1956 | A |
3093135 | Hirschhorn | Jun 1963 | A |
3132688 | Nowak | May 1964 | A |
3282267 | Wiliam | Nov 1966 | A |
3502080 | Hirschhorn | Mar 1970 | A |
3587577 | Smimov et al. | Jun 1971 | A |
3591645 | Selwitz | Jul 1971 | A |
3703897 | Mack et al. | Nov 1972 | A |
3710784 | Taylor | Jan 1973 | A |
3786814 | Armao | Jan 1974 | A |
3827436 | Stumpf et al. | Aug 1974 | A |
3942519 | Shock | Mar 1976 | A |
3948269 | Zimmer | Apr 1976 | A |
3986385 | Johnston et al. | Oct 1976 | A |
4002221 | Buchalter | Jan 1977 | A |
4140130 | Storm, III | Feb 1979 | A |
4178429 | Scheffer | Dec 1979 | A |
4202336 | van Gerven et al. | May 1980 | A |
4266043 | Fujii et al. | May 1981 | A |
4381009 | Del Bon et al. | Apr 1983 | A |
4396011 | Mack et al. | Aug 1983 | A |
4483341 | Witteles | Nov 1984 | A |
4528979 | Marchenko et al. | Jul 1985 | A |
4531524 | Mioduski | Jul 1985 | A |
4548212 | Leung | Oct 1985 | A |
4555313 | Duchane et al. | Nov 1985 | A |
4585002 | Kissin | Apr 1986 | A |
4603076 | Bowditch et al. | Jul 1986 | A |
4614191 | Perler | Sep 1986 | A |
4644955 | Mioduski | Feb 1987 | A |
4664110 | Schanzlin | May 1987 | A |
4700701 | Montaldi | Oct 1987 | A |
4718429 | Smidt et al. | Jan 1988 | A |
4741338 | Miyamae | May 1988 | A |
4764463 | Mason et al. | Aug 1988 | A |
4802475 | Weshahy et al. | Feb 1989 | A |
4832022 | Tjulkov et al. | May 1989 | A |
4846176 | Golden | Jul 1989 | A |
4850340 | Onishi | Jul 1989 | A |
4869250 | Bitterly | Sep 1989 | A |
4880564 | Abel et al. | Nov 1989 | A |
4906463 | Cleary et al. | Mar 1990 | A |
4930317 | Klein | Jun 1990 | A |
4935345 | Guilbeau et al. | Jun 1990 | A |
4961422 | Marchosky et al. | Oct 1990 | A |
4962761 | Golden | Oct 1990 | A |
4990144 | Blott | Feb 1991 | A |
5007433 | Hermsdorffer et al. | Apr 1991 | A |
5018521 | Campbell | May 1991 | A |
5065752 | Sessions et al. | Nov 1991 | A |
5069208 | Noppel et al. | Dec 1991 | A |
5084671 | Miyata et al. | Jan 1992 | A |
5108390 | Potocky et al. | Apr 1992 | A |
5119674 | Nielsen et al. | Jun 1992 | A |
5143063 | Fellner | Sep 1992 | A |
5148804 | Hill et al. | Sep 1992 | A |
5169384 | Bosniak et al. | Dec 1992 | A |
5197466 | Marchosky et al. | Mar 1993 | A |
5207674 | Hamilton | May 1993 | A |
5221726 | Dabi et al. | Jun 1993 | A |
5264234 | Windhab et al. | Nov 1993 | A |
5277030 | Miller | Jan 1994 | A |
5314423 | Seney | May 1994 | A |
5330745 | McDow | Jul 1994 | A |
5334131 | Omandam et al. | Aug 1994 | A |
5336616 | Livesey et al. | Aug 1994 | A |
5339541 | Owens | Aug 1994 | A |
5342617 | Gold | Aug 1994 | A |
5351677 | Kami et al. | Oct 1994 | A |
5362966 | Rosenthal et al. | Nov 1994 | A |
5427772 | Hagan | Jun 1995 | A |
5433717 | Rubinsky et al. | Jul 1995 | A |
5456703 | Beeuwkes, III | Oct 1995 | A |
5472416 | Blugerman et al. | Dec 1995 | A |
5497596 | Zatkulak | Mar 1996 | A |
5505726 | Meserol | Apr 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5507790 | Weiss et al. | Apr 1996 | A |
5514105 | Goodman, Jr. et al. | May 1996 | A |
5514170 | Mauch | May 1996 | A |
5531742 | Barken | Jul 1996 | A |
5562604 | Yablon et al. | Oct 1996 | A |
5571801 | Segall et al. | Nov 1996 | A |
5603221 | Maytal et al. | Feb 1997 | A |
5628769 | Saringer | May 1997 | A |
5647868 | Chinn | Jul 1997 | A |
5650450 | Lovette et al. | Jul 1997 | A |
5651773 | Perry et al. | Jul 1997 | A |
5654279 | Rubinsky et al. | Aug 1997 | A |
5654546 | Lindsay | Aug 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5672172 | Zupkas | Sep 1997 | A |
5733280 | Avitall | Mar 1998 | A |
5741248 | Stern et al. | Apr 1998 | A |
5746736 | Tankovich | May 1998 | A |
5755663 | Larsen et al. | May 1998 | A |
5755753 | Knowlton | May 1998 | A |
5759182 | Varney et al. | Jun 1998 | A |
5759764 | Polovina | Jun 1998 | A |
5769879 | Richards et al. | Jun 1998 | A |
5785955 | Fischer | Jul 1998 | A |
5817050 | Klein | Oct 1998 | A |
5830208 | Muller | Nov 1998 | A |
5833685 | Tortal et al. | Nov 1998 | A |
5844013 | Kenndoff et al. | Dec 1998 | A |
5871524 | Knowlton | Feb 1999 | A |
5871526 | Gibbs et al. | Feb 1999 | A |
5895418 | Saringer et al. | Apr 1999 | A |
5901707 | Gonçalves et al. | May 1999 | A |
5902256 | Benaron | May 1999 | A |
5919219 | Knowlton | Jul 1999 | A |
5948011 | Knowlton | Sep 1999 | A |
5964092 | Tozuka et al. | Oct 1999 | A |
5964749 | Eckhouse et al. | Oct 1999 | A |
5967976 | Larsen et al. | Oct 1999 | A |
5986167 | Arteman et al. | Nov 1999 | A |
6017337 | Pira | Jan 2000 | A |
6023932 | Johnston et al. | Feb 2000 | A |
6032675 | Rubinsky | Mar 2000 | A |
6039694 | Larson et al. | Mar 2000 | A |
6041787 | Rubinsky | Mar 2000 | A |
6049927 | Thomas et al. | Apr 2000 | A |
6051159 | Hao et al. | Apr 2000 | A |
6074415 | Der Ovanesian | Jun 2000 | A |
6093230 | Johnson, III et al. | Jul 2000 | A |
6102885 | Bass | Aug 2000 | A |
6120519 | Weber et al. | Sep 2000 | A |
6241753 | Knowlton | Jun 2001 | B1 |
6264649 | Whitcroft et al. | Jul 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6290988 | Van Vilsteren et al. | Sep 2001 | B1 |
6311090 | Knowlton | Oct 2001 | B1 |
6311497 | Chung et al. | Nov 2001 | B1 |
6350276 | Knowlton | Feb 2002 | B1 |
6354297 | Eiseman | Mar 2002 | B1 |
6357907 | Cleveland et al. | Mar 2002 | B1 |
6377854 | Knowlton | Apr 2002 | B1 |
6377855 | Knowlton | Apr 2002 | B1 |
6381497 | Knowlton | Apr 2002 | B1 |
6381498 | Knowlton | Apr 2002 | B1 |
6387380 | Knowlton | May 2002 | B1 |
6405090 | Knowlton | Jun 2002 | B1 |
6413255 | Stern | Jul 2002 | B1 |
6425912 | Knowlton | Jul 2002 | B1 |
6426445 | Young et al. | Jul 2002 | B1 |
6430446 | Knowlton | Aug 2002 | B1 |
6430956 | Haas et al. | Aug 2002 | B1 |
6438424 | Knowlton | Aug 2002 | B1 |
6438964 | Giblin | Aug 2002 | B1 |
6453202 | Knowlton | Sep 2002 | B1 |
6458888 | Hood et al. | Oct 2002 | B1 |
6461378 | Knowlton | Oct 2002 | B1 |
6470216 | Knowlton | Oct 2002 | B1 |
6471693 | Carroll et al. | Oct 2002 | B1 |
6494844 | Van Bladel et al. | Dec 2002 | B1 |
6519964 | Bieberich | Feb 2003 | B2 |
6523354 | Tolbert | Feb 2003 | B1 |
6527765 | Kelman et al. | Mar 2003 | B2 |
6544248 | Bass | Apr 2003 | B1 |
6548297 | Kuri-Harcuch et al. | Apr 2003 | B1 |
6551348 | Blalock et al. | Apr 2003 | B1 |
6551349 | Lasheras et al. | Apr 2003 | B2 |
6569189 | Augustine et al. | May 2003 | B1 |
6592577 | Abboud et al. | Jul 2003 | B2 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6626854 | Friedman et al. | Sep 2003 | B2 |
6635053 | Lalonde et al. | Oct 2003 | B1 |
6645162 | Friedman et al. | Nov 2003 | B2 |
6645229 | Matsumura et al. | Nov 2003 | B2 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
6682524 | Elbrecht et al. | Jan 2004 | B1 |
6699266 | Lachenbruch et al. | Mar 2004 | B2 |
6718785 | Bieberich | Apr 2004 | B2 |
6741895 | Gafni et al. | May 2004 | B1 |
6746474 | Saadat | Jun 2004 | B2 |
6749624 | Knowlton | Jun 2004 | B2 |
6764502 | Bieberich | Jul 2004 | B2 |
6789545 | Littrup et al. | Sep 2004 | B2 |
6820961 | Johnson | Nov 2004 | B2 |
6821274 | McHale et al. | Nov 2004 | B2 |
6840955 | Ein | Jan 2005 | B2 |
6878144 | Altshuler et al. | Apr 2005 | B2 |
6904956 | Noel | Jun 2005 | B2 |
6918903 | Bass | Jul 2005 | B2 |
6942022 | Blangetti et al. | Sep 2005 | B2 |
6945942 | Van Bladel et al. | Sep 2005 | B2 |
6948903 | Ablabutyan et al. | Sep 2005 | B2 |
7005558 | Johansson et al. | Feb 2006 | B1 |
7022121 | Stern et al. | Apr 2006 | B2 |
7037326 | Lee | May 2006 | B2 |
7077858 | Fletcher et al. | Jul 2006 | B2 |
7081111 | Svaasand et al. | Jul 2006 | B2 |
7096204 | Chen et al. | Aug 2006 | B1 |
7112712 | Ancell | Sep 2006 | B1 |
7115123 | Knowlton et al. | Oct 2006 | B2 |
7183360 | Daniel et al. | Feb 2007 | B2 |
7189252 | Krueger | Mar 2007 | B2 |
7192426 | Baust et al. | Mar 2007 | B2 |
7204832 | Altshuler et al. | Apr 2007 | B2 |
7220778 | Anderson et al. | May 2007 | B2 |
7713266 | Elkins et al. | May 2010 | B2 |
7854754 | Ting et al. | Dec 2010 | B2 |
20010031459 | Fahy et al. | Oct 2001 | A1 |
20010039439 | Elkins et al. | Nov 2001 | A1 |
20010045104 | Bailey et al. | Nov 2001 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020058975 | Bieberich | May 2002 | A1 |
20020062142 | Knowlton | May 2002 | A1 |
20020103520 | Latham | Aug 2002 | A1 |
20020117293 | Campbell | Aug 2002 | A1 |
20020120315 | Furuno et al. | Aug 2002 | A1 |
20020151887 | Stern et al. | Oct 2002 | A1 |
20020156509 | Cheung | Oct 2002 | A1 |
20020188286 | Quijano et al. | Dec 2002 | A1 |
20030044764 | Soane et al. | Mar 2003 | A1 |
20030055414 | Altshuler et al. | Mar 2003 | A1 |
20030069618 | Smith et al. | Apr 2003 | A1 |
20030077329 | Kipp et al. | Apr 2003 | A1 |
20030079488 | Bieberich | May 2003 | A1 |
20030100936 | Altshuler et al. | May 2003 | A1 |
20030109908 | Lachenbruch et al. | Jun 2003 | A1 |
20030109910 | Lachenbruch et al. | Jun 2003 | A1 |
20030125649 | McIntosh et al. | Jul 2003 | A1 |
20030199226 | Sommer et al. | Oct 2003 | A1 |
20030220674 | Anderson et al. | Nov 2003 | A1 |
20030236487 | Knowlton | Dec 2003 | A1 |
20040006328 | Anderson | Jan 2004 | A1 |
20040009936 | Tang et al. | Jan 2004 | A1 |
20040030332 | Knowlton et al. | Feb 2004 | A1 |
20040034341 | Altshuler et al. | Feb 2004 | A1 |
20040039312 | Hillstead et al. | Feb 2004 | A1 |
20040044384 | Leber et al. | Mar 2004 | A1 |
20040049178 | Abboud et al. | Mar 2004 | A1 |
20040073079 | Altshuler et al. | Apr 2004 | A1 |
20040074629 | Noel | Apr 2004 | A1 |
20040093042 | Altshuler et al. | May 2004 | A1 |
20040104012 | Zhou et al. | Jun 2004 | A1 |
20040159109 | Harvie | Aug 2004 | A1 |
20040162596 | Altshuler et al. | Aug 2004 | A1 |
20040199226 | Shadduck | Oct 2004 | A1 |
20040210214 | Knowlton | Oct 2004 | A1 |
20040210287 | Greene | Oct 2004 | A1 |
20040249427 | Nabilsi | Dec 2004 | A1 |
20040259855 | Anderson et al. | Dec 2004 | A1 |
20050049661 | Koffroth | Mar 2005 | A1 |
20050154431 | Quistgaard et al. | Jul 2005 | A1 |
20050159986 | Breeland et al. | Jul 2005 | A1 |
20050182462 | Chornenky et al. | Aug 2005 | A1 |
20050187597 | Vanderschuit | Aug 2005 | A1 |
20050222565 | Manstein | Oct 2005 | A1 |
20050251120 | Anderson et al. | Nov 2005 | A1 |
20050283144 | Shiono et al. | Dec 2005 | A1 |
20060030778 | Mendlein et al. | Feb 2006 | A1 |
20060036300 | Kreindel | Feb 2006 | A1 |
20060074313 | Slayton et al. | Apr 2006 | A1 |
20060079852 | Bubb et al. | Apr 2006 | A1 |
20060122509 | Desilets | Jun 2006 | A1 |
20060200063 | Munro et al. | Sep 2006 | A1 |
20060234899 | Nekmard et al. | Oct 2006 | A1 |
20060270745 | Hunt et al. | Nov 2006 | A1 |
20060293734 | Scott et al. | Dec 2006 | A1 |
20070010861 | Anderson et al. | Jan 2007 | A1 |
20070032561 | Lin et al. | Feb 2007 | A1 |
20070129714 | Elkins et al. | Jun 2007 | A1 |
20070141265 | Thomson | Jun 2007 | A1 |
20070198071 | Ting et al. | Aug 2007 | A1 |
20070239075 | Rosenberg et al. | Oct 2007 | A1 |
20070249519 | Guha et al. | Oct 2007 | A1 |
20070255187 | Branch | Nov 2007 | A1 |
20070255362 | Levinson et al. | Nov 2007 | A1 |
20070282249 | Quisenberry et al. | Dec 2007 | A1 |
20080046047 | Jacobs | Feb 2008 | A1 |
20080077201 | Levinson et al. | Mar 2008 | A1 |
20080077202 | Levinson | Mar 2008 | A1 |
20080140371 | Warner | Jun 2008 | A1 |
20080183164 | Elkins et al. | Jul 2008 | A1 |
20080188915 | Mills et al. | Aug 2008 | A1 |
20090018623 | Levinson et al. | Jan 2009 | A1 |
20090054882 | Hansen et al. | Feb 2009 | A1 |
20090118722 | Ebbers et al. | May 2009 | A1 |
20090149929 | Levinson et al. | Jun 2009 | A1 |
20090149930 | Schenck | Jun 2009 | A1 |
20090312676 | Rousso et al. | Dec 2009 | A1 |
20090318851 | Schenck | Dec 2009 | A1 |
20100081971 | Allison | Apr 2010 | A1 |
20100198204 | Rogers | Aug 2010 | A1 |
20100280582 | Baker et al. | Nov 2010 | A1 |
20110077723 | Parish et al. | Mar 2011 | A1 |
20120022518 | Levinson | Jan 2012 | A1 |
20120239123 | Weber et al. | Sep 2012 | A1 |
20130331914 | Lee et al. | Dec 2013 | A1 |
20140005759 | Fahey et al. | Jan 2014 | A1 |
Number | Date | Country |
---|---|---|
1511503 | Jul 2004 | CN |
1741777 | Mar 2006 | CN |
1817990 | Aug 2006 | CN |
532976 | Sep 1931 | DE |
2851602 | Jun 1980 | DE |
4213584 | Nov 1992 | DE |
4224595 | Jan 1994 | DE |
0263069 | Apr 1988 | EP |
0397043 | Nov 1990 | EP |
0406244 | Jan 1991 | EP |
0598824 | Jun 1994 | EP |
2286660 | Aug 1995 | GB |
2323659 | Sep 1998 | GB |
63076895 | Apr 1988 | JP |
03051964 | Mar 1991 | JP |
3259975 | Nov 1991 | JP |
4093597 | Mar 1992 | JP |
6282977 | Oct 1994 | JP |
7194666 | Aug 1995 | JP |
7268274 | Oct 1995 | JP |
09164163 | Jun 1997 | JP |
10216169 | Aug 1998 | JP |
10223961 | Aug 1998 | JP |
3065657 | Nov 1999 | JP |
2000503154 | Mar 2000 | JP |
2002543668 | Dec 2002 | JP |
2004013600 | Jan 2004 | JP |
2004073812 | Nov 2004 | JP |
2005039790 | Feb 2005 | JP |
3655820 | Mar 2005 | JP |
200565984 | Mar 2005 | JP |
2005110755 | Apr 2005 | JP |
2005520608 | Jul 2005 | JP |
2008323716 | Nov 2005 | JP |
2006026001 | Feb 2006 | JP |
2006520949 | Sep 2006 | JP |
2008532591 | Aug 2008 | JP |
1020040094508 | Nov 2004 | KR |
532976 | Nov 1978 | SU |
0476644 | Feb 2002 | TW |
WO8503216 | Aug 1985 | WO |
WO9404116 | Mar 1994 | WO |
WO-9637158 | Nov 1996 | WO |
WO9637158 | Nov 1996 | WO |
WO9636293 | Nov 1996 | WO |
WO-9636293 | Nov 1996 | WO |
WO9705828 | Feb 1997 | WO |
WO-9705828 | Feb 1997 | WO |
WO9722262 | Jun 1997 | WO |
WO-9722262 | Jun 1997 | WO |
WO-9841157 | Sep 1998 | WO |
WO-9841156 | Sep 1998 | WO |
WO9841157 | Sep 1998 | WO |
WO9938469 | Aug 1999 | WO |
WO-9938469 | Aug 1999 | WO |
WO-0044346 | Aug 2000 | WO |
WO0067685 | Nov 2000 | WO |
WO2001014012 | Mar 2001 | WO |
WO-0205736 | Jan 2002 | WO |
WO-02102921 | Dec 2002 | WO |
WO-03007859 | Jan 2003 | WO |
WO-03078596 | Sep 2003 | WO |
WO200307859 | Sep 2003 | WO |
WO-2004000098 | Dec 2003 | WO |
WO-2004080279 | Sep 2004 | WO |
WO-2005046540 | May 2005 | WO |
WO-2006066226 | Jun 2006 | WO |
WO2006094348 | Sep 2006 | WO |
WO-2006127467 | Nov 2006 | WO |
WO-2007041642 | Apr 2007 | WO |
WO2007127924 | Nov 2007 | WO |
WO2008039557 | Apr 2008 | WO |
WO2008143678 | Nov 2008 | WO |
WO2009026471 | Feb 2009 | WO |
WO-2010077841 | Jul 2010 | WO |
WO-2010127315 | Nov 2010 | WO |
WO-2012012296 | Jan 2012 | WO |
WO2012103242 | Aug 2012 | WO |
Entry |
---|
Office Action; Canadian Patent Application No. 2,585,192; Applicant: Zeltiq Aesthetics, Inc.; Mailed on Nov. 13, 2008; 3 pages. |
U.S. Appl. No. 11/435,502, filed May 17, 2006, Levinson. |
U.S. Appl. No. 11/528,189, filed Sep. 26, 2006, Levinson et al. |
U.S. Appl. No. 11/741,271, filed Apr. 27, 2007, Levinson et al. |
U.S. Appl. No. 11/750,953, filed May 18, 2007, Rosen et al. |
U.S. Appl. No. 11/777,992, filed Jul. 13, 2007, Levinson et al. |
U.S. Appl. No. 11/777,995, filed Jul. 13, 2007, Levinson et al. |
U.S. Appl. No. 11/777,999, filed Jul. 13, 2007, Levinson et al. |
U.S. Appl. No. 11/778,001, filed Jul. 13, 2007, Levinson et al. |
U.S. Appl. No. 11/778,003, filed Jul. 13, 2007, Levinson et al. |
Ardevol et al., “Cooling rates of tissue samples during freezing with liquid nitrogen,” J. of Biochem and Biophysical Methods, Aug. 1993, 27:77-86, Elsevier Science Publishers B.V. |
Bondei et al., “Disorders of Subcutaneous Tissue (Cold Panniculitis),” Dermatology in General Medicine, Fourth Edition, vol. 1, Chapter 108, 1993, Section 16, pp. 1333-1334. |
Burge et al., “Hair Follicle Destruction and Regeneration in Guinea Pig Skin after Cutaneous Freeze Injury,” Cryobiology, 1990, 27(2):153-163. |
Duncan et al., “Cold Panniculitis,” Arch. Derm., Dec. 1966, 94:722-24. |
Epstein et al., “Popsicle Panniculitis,” The New England Journal of Medicine, Apr. 23, 1970, 282(17):966-67. |
Gage “Current Progress in Cryosurgery,” Cryobiology 25, 1988, pp. 483-486. |
Heller-Page et al., “Temperature-dependent skin disorders,” Journal of the American Academy of Dermatology, May 1988, vol. 18, No. 5, Pt 1, pp. 1003-1019. |
Hemmingsson et al, “Attenuation in Human Muscle and Fat Tissue in Vivo and in Vitro,” Acta Radiologica Diagnosis, 1982, 23, 149-151. |
Henry et al., “Les Dermatoses Hivemales,” Rev Med Liege, 1999, 54:11, 864-866. [Abstract Attached]. |
Holman et al., “Variation in Cryolesion Penetration Due to Probe Size and Tissue Thermal Conductivity,” The Annals of Thoracic Surgery, 1992, vol. 53, pp. 123-126. |
Hong et al., “Patterns of Ice Formation in Normal and Malignant Breast Tissue,” Cryobiology 31, 1994, pp. 109-120. |
Kellum et al., “Sclerema Neonatorum: Report of Case and Analysis of Subcutaneous and Epidermal-Dermal Lipids by Chromatographic Methods,” Arch. Derm., Apr. 1968, 97:372-80. |
Koska et al., “Endocrine Regulation of Subcutaneous Fat Metabolism During Cold Exposure in Humans,” Ann. N.Y. Acad, Sci., 2002, 967:500-05. |
Laugier et al., “In Vivo Results with a New Device for Ultrasonic Monitoring of Pig Skin Cryosurgery: The Echographic Cryprobe,” The Society for Investigative Dermatology, Inc., Aug. 1998, vol. 111, No. 2, pp. 314-319. |
Maize, J.C., “Panniculitis,” Cutaneous Pathology, Chapter 13: 327-344, 1998. |
Malcom et al., “Fatty acid composition of adipose tissue in humans: differences between subcutaneous sites,” Am. J. Clin. Nutr., 1989, 50:288-91. |
Moschella et al., “Diseases of the Subcutaneous Tissue,” Dermatology, 1985, Second Ed., vol. 2, Chapter 19, Section II, pp. 1169-1181, W. B. Saunders Company. |
Murphy et al., “Frostbite: Pathogensesis and Treatment,” The Journal of Trauma: Injury, Infection, and Critical Care, Jan. 2000, 48(1):171-178. |
Nagore et al., “Lipoatrophia semicircularis-a traumatic panniculitis: Report of seven cases and review of the literature,” Journal of the American Academy of Dermatology, Nov. 1998, 39:879-81. |
Pease et al., “An Integrated Probe for Magnetic Resonance Imaging Monitored Skin Cryosurgery,” Journal of Biomedical Engineering, Feb. 1995, vol. 117, No. 1, pp. 59-63. |
Pech et al., “Attenuation values, volume changes and artifacts in tissue due to freezing,” Acta Radiologica 6, Nov.-Dec. 1987, 28(6):779-82. |
Phinney et al., “Human Subcutaneous Adipose Tissue Shows Site-Specific Differences in Fatty Acid Composition,” Am. J. Clin. Nutr., 1994, 60:725-29. |
Rabi et al., “Metabolic adaptations in brown adipose tissue of the hamster in extreme ambient temperatures,” American Journal of Physiology, Jul. 1976, vol. 231, Issue 1, pp. 153-160. |
Renold, A.E., “Adipose Tissue,” Handbook of Physiology, American Physiological Society, 1965, Chapter 15, pp. 170-176. |
Rubinsky et al., “Cryosurgery: advances in the application of low temperatures to medicine,” International Journal of Refrigeration, Jul. 1991, 14(4):190-199. |
Shephard, “Adaptation to Exercise in the Cold,” Sports Medicine, 1985, 2:59-71. |
Winkler et al., “Gene Transfer in Laboratory Fish: Model Organisms for the Analysis of Gene Function,” Transgenic Animals, 1997, pp. 387-95. |
Young et al., “Isolation of Embryonic Chick Myosatellite and Pluripotent Stem Cells,” J. Tiss. Cult. Meth., Jun. 1992, 14(2):85-92, Springer Netherlands. |
Coban, “Ischemia-Reperfusion Injury of Adipofascial Tissue: An Experimental Study Evaluating early Histologic and Biochemical Alterations in Rats,” Mediators of Inflammation, 2005, 5, 304-308. |
Liu, A. Y.-C., et al., “Transient Cold Shock Induces the Heat Shock Response upon Recovery at 37 ° C in Human Cells,” J. Biol. Chem., May 20, 1994, 269(20), 14768-14775. |
Nishikawa, “Ultrastructural Changes and Lipid Peroxidation in Rat Adipomusculocutaneous Flap Isotransplants after Normothermic Storage and Reperfusion,” Transplantation,1992, 54, 795-801. |
International Search Report for Application: PCT/2007/075935/ Zeltiq Aesthetics, Inc.; Date of Mailing: Apr. 10, 2008 (4 pages). |
U.S. Appl. No. 12/196,246, filed Aug. 21, 2008, Levinson. |
U.S. Appl. No. 12/275,002, filed Nov. 20, 2008, Martens. |
U.S. Appl. No. 12/275,014, filed Nov. 20, 2008, Martens. |
U.S. Appl. No. 12/337,544, filed Dec. 17, 2008, Alison. |
Bohm et al., “Saline-enhanced radiofrequency ablation of breat tissue: an in vitro feasibility study,” Invest Radiol, 2000, pp. 149-157, vol. 35—issue (3). |
Donski et al., “The Effects of Cooling no Experimental Free Flap Survival,” Brit J Plas Surg, 1980, pp. 353-360, vol. 33. |
Hale et al., “Influence of chronic heat exposure and prolonged food deprivation on execretion of mahnesium, phosphorus, calcium, hydrogen ion & ketones,” Aerosp Med, 1968, pp. 919-926, vol. 39—issue (9). |
International Search Report and Written Opinion for PCT/US2007/023492; Applicant: Zeltiq Aesthetics, Inc.; Date of Mailing: May 15, 2008, 7 pages. |
International Search Report and Written Opinion for PCT/US2007/062508; Applicant: Juniper Medical, Inc.; Date of Mailing: Jul. 20, 2007, 13 pages. |
International Search Report and Written Opinion for PCT/US2007/064016; Applicant: Juniper Medical, Inc.; Date of Mailing: Jul. 20, 2007, 13 pages. |
International Search Report and Written Opinion for PCT/US2007/064017; Applicant: Juniper Medical, Inc.; Date of Mailing: Oct. 26, 2007, 16 pages. |
International Search Report and Written Opinion for PCT/US2007/064018; Applicant: Juniper Medical, Inc.; Date of Mailing: Jul. 26, 2007, 13 pages. |
International Search Report and Written Opinion for PCT/US2007/067638; Applicant: Juniper Medical, Inc.; Date of Mailing: Jan. 10, 2008, 11 pages. |
International Search Report and Written Opinion for PCT/US2007/069694; Applicant: Juniper Medical, Inc.; Date of Mailing: Nov. 23, 2007, 12 pages. |
International Search Report and Written Opinion for PCT/US2007/083255; Applicant: Zeltiq Aesthetics, Inc.; Date of Mailing: Aug. 11, 2008, 8 pages. |
International Search Report and Written Opinion for PCT/US2008/073930; Applicant: Zeltiq Aesthetics, Inc.; Date of Mailing: Nov. 7, 2008, 10 pages. |
International Search Report for EP07758558.6; Applicant: Zeltiq Aesthetics, Inc.; Mailed on Jul. 20, 2007, 4 pages. |
International Search Report for PCT/US2005/045988; (Apr. 25, 2006). |
Kundu et al., “Breath acetone analyzer: diagnostic tool to monitor dietary fat loss,” Clin Chem, 1993, pp. 87-92, vol. 39, issue (1). |
Kundu et al., “Novel solid-phase assay of ketone bodies in urine,” Clin Chem, 1991, pp. 1565-1569, vol. 37—issue (9). |
Kuroda et al., “Thermal distribution of radio-frequency inductive hyperthermia using an inductive aperture-type applicator: evaluation of the effect of tumour size and depth,” Med Biol Eng Comput, 1999, pp. 285-290, vol. 37—issue (3). |
Levchenko, et al., “Effect of dehydration on lipid metabolism,” WMJ, 1978, pp. 95-97, vol. 50—issue (1). |
Lidagoster, MD et al., “Comparison of Autologous Fat Transfer in Fresh, Refridgerated, and Frozen Specimens: An Animal Model Presented,” at the 16th Annual Meeting of the Northeastern Society of Plastic Surgeons: Burlington, VT, 1999, pp. 512-515. |
Lvova, “Lipid levels and lipid peroxidation in frog tissues during hypothermia and hibernation,” WMJ, 1990, pp. 65-70, vol. 62—issue (1). |
Nagao et al., “Dietary diacylglycerol suppresses accumulation of body fat compared to triacylglycerol in men a double-blind controlled trial,” J Nutr, 2000, pp. 792-797, vol. 130—issue (4). |
Nielsen, “Thermoregulation In Rest and Exercise,” Acta Phys Scan Supp, 1969, pp. 6-74, vol. 323. |
Non-Final Office Action; U.S. Appl. No. 11/435,502; Date of Mailing: Jul. 17, 2009, 10 pages. |
Peterson et al., “Bilateral Fat Necrosis of the Scrotum, Urology Service, Department of Surgery, Dermatology Service, Department of Medicine and Department of Pediatrics,” Letterman Army Medical Center, Journal of Urology, 1976, pp. 825-826, vol. 116, The Williams & Wilkins Co. |
Schoning, et al., “Experimental Frostbite: Freezing Times, Rewarming Times, and Lowest Temperatures of Pig Skin Exposed to Chilled Air,” Cryobiology, 1990, pp. 189-193, 27. |
Final Office Action; U.S. Appl. No. 10/391,221; Date of Mailing: Aug. 24, 2006, 4 pages. |
Final Office Action; U.S. Appl. No. 11/016,196; Date of Mailing: Mar. 23, 2010, 12 pages. |
Final Office Action; U.S. Appl. No. 11/435,502; Date of Mailing: Mar. 29, 2010, 11 pages. |
International Search Report and Written Opinion for PCT/US2009/058088; Applicant: Zeltiq Aesthetics, Inc.; Date of Mailing: Nov. 20, 2009, 14 pages. |
International Search Report and Written Opinion for PCT/US2009/067973; Applicant Zeltiq Aesthetics, Inc.; Date of Mailing: Feb. 18, 2010, 10 pages. |
Non-Final Office Action; U.S. Appl. No. 10/391,221; Date of Mailing: Jul. 22, 2005, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 10/391,221; Date of Mailing: Jan. 25, 2006, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 10/391,221; Date of Mailing: May 30, 2007, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 11/016,196; Date of Mailing: Sep. 25, 2009, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 11/016,196; Date of Mailing: Apr. 22, 2008, 11 pages. |
Non-Final Office Action; U.S. Appl. No. 11/359,092; Mailed on Nov. 19, 2009, 13 pages. |
Pre-Interview Office Action; U.S. Appl. No. 11/434,478; Date of Mailing: May 6, 2010, 4 pages. |
European Search Report, European Patent Application No. 10167756.5, Applicant: The General Hospital Corporation, Mailing Date: Aug. 31, 2010, 6 pages. |
Final Office Action; U.S. Appl. No. 11/558,046; Date of Mailing: Mar. 30, 2011, 17 pages. |
International Search Report and Written Opinion for PCT/US2010/033290; Applicant: Zeltiq Aesthetics, Inc.; Mailed on Feb. 25, 2011, 12 pages. |
International Search Report and Written Opinion for PCT/US2011/022112; Applicant: Zeltiq Aesthetics, Inc.; Mailed on Mar. 18, 2011, 11 pages. |
International Search Report and Written Opinion for PCT/US2011/022444; Applicant: Zeltiq Aesthetics, Inc., Mailed on Mar. 29, 2011, 14 pages. |
Merrill, Tom, “A Chill to the Heart: A System to Deliver Local Hypothermia Could One Day Improve the Lives of Heart-Attack Patients,” Mechanical Engineering Magazine, Oct. 2010 (10 pages). |
Non-Final Office Action; U.S. Appl. No. 11/558,046; Date of Mailing: Jul. 12, 2010, 14 pages. |
Non-Final Office Action; U.S. Appl. No. 11/741,271; Date of Mailing: Jul. 12, 2010, 9 pages. |
Wang et al., “Cryopreservation of cell/hydrogel constructs based on a new cell-assembling technique”, Sep. 5, 2009, 40 pages. |
Wharton et al., “Cold acclimation and cryoprotectants in a freeze-tolerant Antarctic nematode, Panagrolaimus davidi,” Mar. 7, 2000, 2 pages. |
Non-Final Office Action; U.S. Appl. No. 12/565,613; Date of Mailing: Sep. 23, 2011, 55 pages. |
Non-Final Office Action; U.S. Appl. No. 12/942,852; Date of Mailing: Jun. 30, 2011, 10 pages. |
European Search Report, Supplement, European Patent Application No. EP08798416.7, Applicant: Zeltiq Aesthetics, Inc., Mailing Date: Jan. 12, 2012, 7 pages. |
Final Office Action; U.S. Appl. No. 12/942,852; Date of Mailing: Mar. 7, 2011, 6 pages. |
European Search Report, Eurpean Patent Application No. EP07761461; Applicant: Zeltiq Aesthetics, Inc., Mailing Date: Apr. 25, 2012, 9 pages. |
European Search Report, Supplement, European Patent Application No. EP09836823, Applicant: Zeltiq Aesthetics, Inc., Mailing Date: May 15, 2012, 5 pages. |
Final Office Action; U.S. Appl. No. 11/741,271; Date of Mailing: Jul. 19, 2012, 8 pages. |
Final Office Action; U.S. Appl. No. 11/750,953; Date of Mailing: Jul. 5, 2012, 11 pages. |
International Search Report and Written Opinion for PCT/US2012/022585; Mailed on May 18, 2012, 14 pages. |
Kumakura et al.; Office Action: Notification of Reason for Rejection; Japanese Patent Application No. 2010-213871; Dispatch No. 254910; Dispatched: Apr. 16, 2012; Drawn up on: Apr. 12, 2012; 4 pages. |
Non-Final Office Action; U.S. Appl. No. 11/777,992; Date of Mailing: Jun. 22, 2012, 5 pages. |
Non-Final Office Action; U.S. Appl. No. 12/337,544; Date of Mailing: Mar. 30, 2012, 13 pgs. |
Number | Date | Country | |
---|---|---|---|
20080077211 A1 | Mar 2008 | US |